Intervacc AB (OSTO:IVACC) Accounts Payable & Accrued Expense : kr0.00 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Intervacc AB Accounts Payable & Accrued Expense?

Intervacc AB's quarterly accounts payable & accrued expense increased from Sep. 2023 (kr0.00 Mil) to Dec. 2023 (kr8.38 Mil) but then declined from Dec. 2023 (kr8.38 Mil) to Mar. 2024 (kr0.00 Mil).

Intervacc AB's annual accounts payable & accrued expense declined from Dec. 2021 (kr9.66 Mil) to Dec. 2022 (kr5.61 Mil) but then increased from Dec. 2022 (kr5.61 Mil) to Dec. 2023 (kr8.38 Mil).

Intervacc AB Accounts Payable & Accrued Expense Historical Data

The historical data trend for Intervacc AB's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intervacc AB Accounts Payable & Accrued Expense Chart

Intervacc AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

4.83

9.55

9.66

5.61

8.38

Intervacc AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															-	-	-	8.38	-

Intervacc AB Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Intervacc AB (OSTO:IVACC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intervacc AB (OSTO:IVACC) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

2E9:Germany

Address

Vastertorpsvagen 135, Hagersten, Stockholm, SWE, S-129 44

Website

https://www.intervacc.se

Intervacc AB is a biotechnology company. It develops new vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care. The company through its subsidiary focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses on the Swedish market.

Intervacc AB (OSTO:IVACC) Headlines

No Headlines